Neuraxial Ultrasound Device Study
Part of paid clinical trials in Stanford, California.
- Sponsor
- Stanford University
- Study ID
- NCT06281249
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cesarean Delivery Regional Anesthesia Induction
- Labor Pain
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ultrasound placement device — DEVICEDevice to assist in placement of epidural procedure
Study Details
The aim of the study is to develop a device that can eliminate failed neuraxial placements in challenging patients.The study will attempt to improve safety and efficacy of neuraxial anesthesia with high precision real-time needle visualization through automated real-time needle guidance at the bedside with an experimental device (Accuro 3S). Investigators will verify the clinical workflow for utilizing the Accuro 3S during epidural and spinal procedures and validation of needle visualization while using the device as well as anatomical guidance provided by the device during spinal imaging.The underlying bone imaging enhancement algorithms were introduced in the commercially available FDA approved Accuro. The Accuro 3S will be used to establish needle insertion point and trajectory, after which the clinician will use standard of care methods to advance the needle such as the loss of resistance method.
Key Dates
- Start date
- Dec 15, 2026
- Status verified
- Apr 2026
- Primary completion
- Jul 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Intrathecal neuraxial procedureParticipants undergoing surgery, receiving neuraxial intrathecal anesthesia with block placement in part by the investigational device.
Primary Outcome Measure
Incidence of difficult block placement [ Time Frame: 15 minutes ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University | Stanford | California | 94305 | - |
Find similar trials in Stanford, CA
Related Studies
- The Stimulation To Induce Mothers StudyPHASE4 · Recruiting · Yale University · New Haven, Connecticut
- ED90 of Bupivacaine After Lidocaine Test Dose with DPE and EPLPHASE4 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Exploring the Effect of AromatherapyEnrolling By Invitation · Baptist Health South Florida · Miami, Florida